S. 1476 · 118th Congress (2023–2025)
Pharmaceutical Research Transparency Act of 2023
This bill requires the disclosure of costs associated with clinical trials and pharmaceutical research and development.
Specifically, the National Institutes of Health must create a publicly available repository of cost data from certain clinical trials that test the efficacy of drugs, biological products, and devices in human subjects. For each applicable trial, the registry must, among other information, include the total and per patient cost of the trial, as well as costs for personnel, health care services, and other categories of expenditures. Information must be added to the registry within one year of the trial's completion.
The bill also requires drug manufacturers to include their research and development expenditures for drugs and biological products in annual disclosures made to the Securities and Exchange Commission.
Show official title
A bill to amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 1476’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Debbie Stabenow (D-MI)
- Cosponsors
2 cosponsors
2 original · 0 later
- Sen. Tina Smith (D-MN)· Original · May 9, 2023
- Sen. Peter Welch (D-VT)· Original · May 9, 2023
- Policy area
- Health
- Subjects
- Administrative law and regulatory procedures
- Department of Health and Human Services
- Government information and archives
- Manufacturing
- Medical research
- Prescription drugs
- Research and development
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Pharmaceutical Research Transparency Act of 2023
Display title, Short title · Introduced in Senate
A bill to amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
Official title · Introduced in Senate